EFFECTS OF CHLORELLA VULGARIS EXTRACT ON CYTOKINES PRODUCTION IN LISTERIA MONOCYTOGENES INFECTED MICE

REFERENCES

• Hasegawa T., Okuda M., Tanaka K., Nomoto K., Yoshikai Y. Augmentation of the Resistance Against Escherichia coli by Oral Administration of a Hot Water Extract of Chlorella vulgaris in Mice. Immunopharmacol. Immunotoxical. 1984; 16: 191
   Google Scholar
• Hasegawa T., Tanaka K., Ueno K., Okuda M., Yoshikai Y., Nomoto K. Augmentation of the Resistance Against Escherichia Coli by Oral Administration of a Hot Water Extract of Chlorella vulgaris. Int. J. Immunopharmacol. 1989; 11: 871
   PubMedGoogle Scholar
• Konishi F., Tanaka K., Kumamoto S., Hasegawa T., Okuda M., Yano I., Yoshikai Y., Nomoto K. Enhanced Resistance Against Escherichia Coli infection by Subcutaneous Administration of the Host-Water Extract of Chlorella vulgaris in Cyclophosphamide-Treated Mice. Cancer Immunol. Immunotherapy 1990; 32: 1
   PubMed Web of Science ®Google Scholar
• Tanaka K., Tomida Y., Tsuruta M., Konishi F., Okuda M., Himeno K., Nomoto K. Oral Administration of Chlorella vulgaris Augments Concomitant Antitumor Immunity. Immunopharmacol. and Immunotoxicol. 1990; 12: 277
   PubMed Web of Science ®Google Scholar
• Hasegawa T., Yoshikai Y., Okuda M., Nomoto K. Accelerated Restoration of Leukocytes Number and Augmentation Resistance Against Escherichia coli in Cyclophophamide-Treated Rats Only Orally Administrated With a Hot Water Extract of Chlorella vulgaris. Int. J. Immunopharmacol. 1990; 12: 8883
   Google Scholar
• Hasegawa T., Kimura Y., Hiromatsu K., Kobayashi N., Yamada A., Makino M., Okuda M., Sano T., Yoshikai Y., Nomoto K. Effects of Hot Extract of Chlorella vulgaris on Cytokine Expression Patterns in Mice with Murine Acquired Immunodeficiency Syndrome After Infection with Listeria monocytogenes. Immunopharmacol. 1997; 35: 273
   PubMed Web of Science ®Google Scholar
• Hasegawa T., Ito K., Ueno S., Kumamoto Y., Ando Y., Yamada K., Nomoto K., Yasunobu Y. Oral Administration of Hot Water Extracts of Chlorella vulgaris Reduces IgE Production Against Milk Casein in Mice. Int. J. Immunopharmacol. 1999; 21: 311
   PubMedGoogle Scholar
• Hasegawa T., Noda K., Kumamoto S., Ando Y., Yamada A., Yoshikai Y. Int. J. Immunopharmacol. 2000; 22: 877
   Google Scholar
• Dantas D.C.M., Queiroz M.L.S. The Effects of on Bone Marrow Progenitor Cells of Mice Infected with Listeria monocytogenes. Int. J. Immunopharmacol. 1999; 21: 499
   PubMed Web of Science ®Google Scholar
• Dantas D.C.M., Kaneno R., Queiroz M.L.S. The Effects of Chlorella vulgaris in the Protection of Mice Infected with Listeria monocytogenes. Role of Natural Killer Cells. Immunopharmacol. and Immunotoxicol. 1999; 21: 609
   PubMed Web of Science ®Google Scholar
• Chen Q., Ghilardi N., Wang H., Baker T., Xie M.H., Gurney A., Grewal I.S., de Sauvage F.J. Development of Th-1 Type Immune Response Requires the Type I Cytokine Receptor TCCR. Nature 2000; 19: 916
   Google Scholar
• Daugelat S., Kaufmann S.H.E. Role of Th1 and Th2 Cells in Bacterial Infection. Chemical Immunol., S. Romagnani>, 1996; 63, 66
   Google Scholar
• Mackaness G.B. Cellular Resistance to Infection. J. Exp. Med. 1962; 116: 381
   PubMed Web of Science ®Google Scholar
• Hahn H., Kaufmann S.H.E. The Role of Cell-Mediated Immunity in Bacterial Infection. Ver. Infect. Dis. 1981; 3: 1221
   Google Scholar
• Nakane A., Numata A., Assano M., Kohanawa M., Chen Y., Minagawa T. Evidence that Endogenous Gamma Interferon is Produced Early Listeria monocytogenes Infection. Infect. Immnunol. 1990; 58: 2386
   PubMedGoogle Scholar
• Nakane A., Numata A., Minagawa T. Endogenous Tumor Necrosis Factor, Interleukin-6 and Gamma Interferon Levels During Listeria monocytogenes Infection in Mice. Infect. Immnunol. 1992; 60: 523
   PubMed Web of Science ®Google Scholar
• Bushmeier N.A., Schreiber R.D. Requirement of Endogenous Interferon-γProduction for Resolution of Listeria monocytogenes Infection. Proc. Nat. Acad. Sci. USA 1985; 82: 7404
   PubMedGoogle Scholar
• Dighe A.S. et al. Tissue-Specific Targeting of Cytokine Unresponsiveness in Transgenic Mice. Immun. 1995; 3: 657
   Google Scholar
• Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aueget M., Schreiber R.D. Targeted Disruption of the Start1 Gene in Mice Reveals Unexpected Physiologic Specific in the JAK-STAT Pathway. Cell 1992; 84: 43
   Google Scholar
• Dalton K.D., Pitts M.S., Keshav S., Figari I., Bradley A., Stewart T.A. Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes. Science 1993; 259: 1739
   PubMed Web of Science ®Google Scholar
• Huang S., et al. Immune Response in Mice that Lack the Interferon-γ Receptor. Science 1993; 259: 1742
   PubMed Web of Science ®Google Scholar
• Tsukada H., Kawamura I., Arakawa M., Nomoto K., Mitsuyama M. Dissociated Development of T cells against Listeria monocytogenes and their Functional Difference in Lymphokine Production. Infect. Immun. 1991; 59: 3589
   PubMedGoogle Scholar
• Xiong H., Nishibori T., Ohya S., Tanabe Y., Mitsuyama M. Involvement of Various Combinations of Endogenous Inflammatory Cytokines in Listeria monocytogenes- induced Expression of Inducible Nitric Oxide Syntase in Mice. FEMS Immunol. Med. Microbiol. 1996; 16: 257
   PubMedGoogle Scholar
• Trip C.S., Gately M.K., Hakimi J., Ling P., Unanue E.R. Neutralization of IL-12 Decreases Resistance to Listeria in SCID and C.B.-17 Mice. Interleukin. J. Immunol. 1994; 152: 1883, Reversal by Trip, C.S.; Wolf, S.F., Unanue, E.R.
   Google Scholar
• Haak-Frendscho M., Brown J.F., Iizawa Y., Wagner R.D., Czupryski C.J. Administration of Anti-4 Monoclonal Antibody 11B11 Increase the Resistance of Mice to Listeria monocytogenes Infection. J. Immunol. 1992; 12: 3978
   Google Scholar
• Trip C.S., Wolf S.F., Unanue E.R. Interleukin 12 and Tumor Necrosis Factor α are Co-stimulators of Interferon-γ Production by Natural Killer Cells in Severe Combined Immunodeficiency Mice with Listeriosis, and Interleukin 10 is a Physiologic Antagonist. Proc. Nat. Acad. Sci, USA. 1993; 90: 3725
   PubMedGoogle Scholar
• Trip C.S., Kanagawa O., Unanue E.R. Secondary Response to Listeria Infection Requires INF-γ but is Partially Independent of IL-12. J. Immunol. 1995; 155: 3427
   PubMedGoogle Scholar
• Tone Y., Thompson S.K., Babik J.M., Nolan K.F., Tone M., Raven C., Waldmann H. Structure and Chromosomal Location of the Mouse Interleukin-12 p35 and p45 Sub-Unit Genes. Eur. J. Immunol. 1996; 26: 1222
   PubMed Web of Science ®Google Scholar
• Kearns R.J., Leu R.W. Modulation of Natural Killer Activity in Mice Following Infection with Listeria monocytogenes. Cell Immunol. 1984; 84
   PubMedGoogle Scholar
• Dunn P.L., North R.J. Early Gamma Interferon Production by Natural Killer Cells is Important in Defense Against Murine Listeriosis. Immun. 1991; 59: 2892
   Google Scholar
• Goossens P.L., Jovin H., Milon G. Dynamics of Lymphocytes and Inflammatory Cells Recruited in Liver During Murine Listeriosis. J. Immunol. 1991; 147: 3514
   PubMed Web of Science ®Google Scholar
• Bancroft G.J. The Role of Natural Killer Cells in Innate Resistance to Infection. Curr. Op. Immunol. 1993; 5: 503
   PubMed Web of Science ®Google Scholar
• Ladel C.H., Blum C., Kaufmann S.H.E. Control of Natural Killer Cell-Mediated Innate Resistance Against the Intracellular Pathogen Listeria monocytogenes by γδ T lymphocytes. Infect. Immun. 1994; 64: 1744
   Google Scholar
• Kaine P.M., Bancroft G.J. Leishmania donavani Infection in SCDI. Lack of Tissue Response in vivo Macrophage Activation Correlates with Failure to Trigger Natural Killer Cell-Derived Gamma Interferon Production in vitro. Infect. Immun. 1992; 60: 4335
   PubMedGoogle Scholar
• Bancroft G.J., Schreiber R.D., Bosna G.C., Bosma M.G., Unanue E.R.A. T-Cell-Independent Mechanism of Macrophage Activation by γ Interferon. J. Immunol. 1987; 139: 1105
   Google Scholar
• Farrar W.L., Johnson H.M., Farrar J.J. Regulation of the Production of Immune Interferon and Cytotoxic T Lymphocytes by Interleukin-2. J. Immunol. 1981; 126: 1120
   PubMed Web of Science ®Google Scholar
• Donahue J.H., Rosenberg S.A. The Fate of Interleukin-2 after Administration in vivo. J. Immunol. 1983; 130: 2203
   PubMedGoogle Scholar
• Zinkernagel R.M., Althage A., Adler B., Blandem R.V., Davidson W.F., Kees U., Dunlop M.B.C., Shreffler D.C. h-2 Restriction of Cell Mediated Immunity to an Intracellular Bacterium. Effector T Cell are Specific for Listeria Antigen Self-Markers. J. Exp. Med. 1977; 145: 1353
   PubMedGoogle Scholar
• Chong K.T. Prophylactic Administration of Interleukin-2 Protects Mice from Lethal Challenge with Gram-Negative Bacteria. Infect. Immunol. 1987; 55: 668
   PubMedGoogle Scholar
• Haak-Frendscho M., Young K.M., Czuprynski C.J. Treatment of Mice with Human Recombinant Interleukin-2 Augments Resistance to the Facultative Intracellular Pathogen Listeria monocytogenes. Infect. Immun. 1989; 57: 3014
   PubMedGoogle Scholar
• Yap S.J., Sher A. Effector Cells of Both Non-hematopoietic and Hematopoietic Origin are Required for Interferon (INF)-γ and Tumor Necrosis Factor (TNF)α-Dependent Host Resistance to the Intracellular Pathogen, Toxoplasma gondi. J. Exp. Med. 1999; 189: 1083
   PubMedGoogle Scholar
• Smith K.A. Interleukin-2, Inception, Impact, and Implications. Science 1988; 240: 1169
   PubMed Web of Science ®Google Scholar
• Limb G.A., Meager A., Wooley J., Wadhwa M., Biggerstag J., Brown K. A., Wolstencroft. Release of Cytokines During Generation of Lymphokine-Activated Killer (LAK) Cells by IL-2. Immunol. 1989; 68: 514
   PubMed Web of Science ®Google Scholar
• Kelly J.P., Bancroft G.J. Administration of Interleukin-10. Adv. Immunol. 1996; 26: 365
   Google Scholar
• Mosmann T.R. Properties and Functions of Interleukin-10. Avd. Immunol. 1993; 56: 1
   Google Scholar
• Mielke M.E.A., Ehlers S., Hahn H. The Role of Cytokines in Experimental Listeriosis. Immunobiol. 1993; 189: 285
   PubMedGoogle Scholar